global-automated-and-rapid-microbiological-tests-market-to-reach-$7.6-billion-by-2026

Global Automated and Rapid Microbiological Tests Market to Reach $7.6 Billion by 2026

New York, Oct. 18, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Automated and Rapid Microbiological Tests Industry” – https://www.reportlinker.com/p04707098/?utm_source=GNW

Clinical diagnostics, environmental applications, and food and beverage testing labs use rapid microbial testing to identify microbes from different types of samples. Growth in the global is set to be fueled by rising global prevalence of chronic infectious diseases, increasing food safety concerns, growing need for fast and easy diagnosis, rising public-private investments, funding, and research grants, and sustained technological advancements. Continued technological advancements in terms of improved functionality, efficiency, efficacy, faster results, and accuracy are driving the adoption of microbial testing in academic institutes, research laboratories, hospitals, clinical laboratories, and biotechnology and pharmaceutical companies. Rapid advancements in microbial testing help in overcoming limitations such as an extensive period of exposure to pathogenic strains and long procedural times associated with traditional testing methods. In addition, these tests serve as a cost-effective alternative to microbial identification by enabling reduction in the consumable cost per procedure.

Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$7.6 Billion by 2026, growing at a CAGR of 6.1% over the analysis period. GC/CRT (Clinical), one of the segments analyzed in the report, is projected to grow at a 7.4% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the AISS (clinical) segment is readjusted to a revised 3.4% CAGR for the next 7-year period. This segment currently accounts for a 10.4% share of the global Automated and Rapid Microbiological Tests market. The surge in the occurrences of STDs, such as GC/Chlamydia, HIV and Syphilis, has turned STD rapid tests into the most dynamic and vigorous segment of the market.

The U.S. Market is Estimated at $2.1 Billion in 2021, While China is Forecast to Reach $709.2 Million by 2026

The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$2.1 Billion in the year 2021. The country currently accounts for a 37.1% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$709.2 Million in the year 2026 trailing a CAGR of 8.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5% CAGR while Rest of European market (as defined in the study) will reach US$766.1 Million by the end of the analysis period. North America and Europe represent the leading regional markets, due to technological advancements related to rapid microbial testing, growing incidences of infectious diseases, and increasing food safety concerns. Asia-Pacific region presents considerable growth opportunities due to the rising healthcare expenditure and expanding initiatives for promotion of the use of advanced technologies in rapid microbiology testing.

ABCS (Clinical) Segment to Reach $530.3 Million by 2026

In the global ABCS (Clinical) segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$372.2 Million in the year 2020 will reach a projected size of US$456.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$32.7 Million by the year 2026, while Latin America will expand at a 3.8% CAGR through the analysis period.

Select Competitors (Total 77 Featured)

  • Abbott Laboratories
  • Abbott Molecular, Inc.
  • Aidian Oy
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • bioMérieux SA
  • bioMerieux, Inc.
  • Bio-Rad Laboratories, Inc
  • Cellabs Pty Ltd
  • Cepheid Inc.
  • CorisBioconcept SPRL
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • MedMira Inc.
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • Oxoid Limited
  • QIAGEN N.V.
  • Quidel Corporation
  • Rapid Micro Biosystems, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.

Read the full report: https://www.reportlinker.com/p04707098/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Impact of COVID-19 Pandemic and Looming Global Recession

EXHIBIT 1: Clinical Microbiology Gains Prominence as Scientists

Mobilize United Efforts to Find Ways to Detect, Treat &

Vaccinate People Against the Novel Coronavirus: COVID-19

Tests Per Million Population by Country (As of 15 June 2021)

A New, 20-Minute Assay for COVID-19 Diagnosis

Automated and Rapid Microbiological Tests: An Introduction

Enabling Technologies of Automated & Rapid Microbiological Tests

Clinical Applications of Automated & Rapid Microbiological Tests

Applications in Non-Clinical Investigations

Global Market Prospects & Outlook

Evolutionary Battle against Microbes Drives Market Future

Clinical Applications Lead the Global Market for Automated and

Rapid Microbiological Testing

Developed Regions Lead, Developing Economies to Boost Future

Growth

Competition

Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rapid Diagnostics Bring in a Transformation to Clinical Testing

Practices

Traditional Rapid Microbiological Tests Make Way for New, Probe

Tests

Lab Automation Trend Augurs Well for Microbiological Testing Labs

Traditional Approaches Give Way to Modern Automated

Microbiology Systems

Microbiology Laboratories Switch to Automation to Push Yields

Growing Incidence of Infectious Diseases to Fuel Demand for

Rapid Microbiology Testing

EXHIBIT 2: Infectious Diseases Remain Major Cause of Death in

Under Developed Regions: Breakdown of Leading Causes of Death

in Sub-Saharan Africa (in %)

EXHIBIT 3: Infectious Diseases Related Mortality High Among

Children Below 5 Years: Breakdown of Leading Causes of Death

in Children Below 5 Years (in %)

Rising Prevalence of Respiratory Infections Drive Market Growth

EXHIBIT 4: Global Number of Deaths Caused Due to Communicable

Diseases (In 000s)

Rise in Prevalence of COPD Augments Demand

EXHIBIT 5: Global Prevalence of COPD: Percentage of Men and

Women Affected by Age Group

Influenza Boosts Rapid Test Prospects

EXHIBIT 6: Flu Related CDC Estimates from October 2019-April 2020

Rise in Pollution Levels Trigger Increase in Respiratory

Diseases, Driving Opportunities for Automated Microbiology

Tests

EXHIBIT 7: Percentage Share Breakdown of Global Deaths Linked

to Air Pollution

EXHIBIT 8: Most Polluted Countries Worldwide: Average PM2.5

concentration (µg/m³) for 2020

Sustained Threat of HIV and Sexually Transmitted Diseases

Amplify Need for Rapid Microbiological Testing

EXHIBIT 9: Global HIV Prevalence: Number of People Living with

AIDs (in Thousands) by Region for 2020

EXHIBIT 10: Number of AIDS-Related Deaths (in Thousands) by

Region for 2018

Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer

Disease

Home HIV Testing Emerges as a Lucrative Option

Advancements in Molecular Diagnostics Drive Market Growth

Emerging Technologies in Clinical Microbiology Diagnostics Aim

at Faster Diagnosis

Automated Blood Culture Systems: The Gold Standard in the Fight

against Bacteremia

Advancements in Molecular Diagnostics: A Boon for Rapid

Microbiological Testing Market

Biotechnology: A Crucial Step Ahead in the Growing Popularity

of Rapid Microbial Tests

Healthcare Needs of the World?s Aging Population: Potential

Opportunity in Store

EXHIBIT 11: Global Aging Population Statistics for the 65+ Age

Group in Million by Geographic Region for the Years 2019,

2025, 2035 and 2050

EXHIBIT 12: Elderly Population (65+ Years) as a % of Total

Population by Developed, Less Developed and Least Developed

Regions: 2019 & 2030

Increase in Healthcare Spending in Emerging Markets to Propel

Demand for Automated Microbiological Testing

EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for

the Years 2017-2023

EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP for

1970, 2010 and 2050

Clinical Microbiology Market Benefits from Digitalization and

Robotization Trend

Integration of Clinical Microbiology with Cloud Computing

Artificial Intelligence Holds Positive Implications for

Automation of Clinical Microbiology

Point-of-Care Rapid Microbiological Testing: Yet to Realize Its

Full Potential

Technological Advancements to Drive the Automated Microbiology

Testing Market

Focus on Safe and High-Quality Foods Propels Rapid

Microbiological Testing

EXHIBIT 15: Number of Food Allergen Recalls in the US:

Breakdown by FDA-Regulated Foods and FSIS-Regulated Foods for

2019

Foodborne Illness Outbreak Investigations in the US (2019 & 2020)

Impact of COVID-19 on Food Safety Testing Industry

Stringent Norms Necessitate Food Safety Testing

Food Microbiology Testing Market on a Growth Spree

EXHIBIT 16: Global Food Safety Testing Market Breakdown (in %)

by Segment for 2020

Rapid and Automated Tests Emerge as an Attractive Solution

Leading Food Processors Exhibit Inclination Towards Rapid

Microbiological Testing

Automation of Food Microbiology Labs

Poultry Industry Embraces Rapid Microbiological Testing

Technologies

Rapid Microbial Testing in Dairy Industry

Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing

Technical and Cost Related Hurdles Hamper the Microbiology

Testing Market

Rapid Microbiological Testing Gains Significance in the

Pharmaceutical Industry

Key Advantages of Rapid Microbiological Tests for

Pharmaceutical Industry

Growing Importance of Rapid Microbiological Testing for Pharma

Laboratories

Key RMM Technologies for Pharmaceutical Industry

Adoption of Rapid Methods for QC Microbiology in

Biopharmaceuticals

Advancements in Rapid Microbiological Testing for

Pharmaceutical Industry

Rapid Microbial Testing for Regenerative Medicine: An Emerging

Space

Rapid Microbiological Methods and the Regulatory Environment in

Drug Development Industry

FDA?s Requirements for Validation of RMM

EMA?s Guidance on Use of RMMs for Water Testing

Rapid Microbial Testing Emerges as an Important Means for

Quality Control of Advanced Therapies

Antibiotic Resistant Bacteria Throws the Spotlight on Rapid

Microbial Testing Tools

Antimicrobial Vulnerability Testing and Identification of

Microbial strains

Role of Microscopy in Antimicrobial Susceptibility Testing

Rising Prominence of NAAT-Driven AST

Economic Factors Promise Growth for Rapid AST

Rapid Technologies Gain Momentum in Environment Testing Field

Deteriorating Quality of Water Throws Emphasis on Water Testing

Services

EXHIBIT 17: Percentage of Contaminated Water in Drinking Water

Supplies in Africa, Asia, and Latin America and Caribbean

Key Issues Confronting the Rapid Microbiological Tests Market

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Current & Future Analysis for Automated and

Rapid Microbiological Tests by Geographic Region – USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets – Independent Analysis of Annual Sales in

US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Automated and Rapid

Microbiological Tests by Geographic Region – USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets – Independent Analysis of Annual Sales in

US$ Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Automated and Rapid

Microbiological Tests by Geographic Region – Percentage

Breakdown of Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets for

Years 2012, 2021 & 2027

Table 4: World Current & Future Analysis for GC/CRT (Clinical)

by Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 5: World Historic Review for GC/CRT (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for GC/CRT (Clinical) by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Current & Future Analysis for AISS (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 8: World Historic Review for AISS (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for AISS (Clinical) by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Current & Future Analysis for ABCS (Clinical)

by Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 11: World Historic Review for ABCS (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for ABCS (Clinical) by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Current & Future Analysis for SIRT (Clinical)

by Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 14: World Historic Review for SIRT (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for SIRT (Clinical) by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Current & Future Analysis for ATS (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 17: World Historic Review for ATS (Clinical) by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for ATS (Clinical) by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Current & Future Analysis for Other

Applications (Clinical) by Geographic Region – USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa Markets – Independent Analysis of Annual Sales in

US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Other Applications

(Clinical) by Geographic Region – USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets – Independent Analysis of Annual Sales in US$ Thousand

for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other Applications

(Clinical) by Geographic Region – Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa for Years 2012, 2021 &

2027

Table 22: World Current & Future Analysis for Non-Clinical by

Geographic Region – USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 23: World Historic Review for Non-Clinical by Geographic

Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets – Independent Analysis

of Annual Sales in US$ Thousand for Years 2012 through 2019 and

% CAGR

Table 24: World 15-Year Perspective for Non-Clinical by

Geographic Region – Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES

Rising Threat of Infectious Diseases Drive Significance of

Rapid Microbiological Testing

EXHIBIT 18: Healthcare Spending as a % of GDP in the US: 2010-2020

COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests

US-based Labs Ramp Up Operations Amidst the COVID-19 Situation

Unmet Diagnostic Needs of Aging Population: Major Driver

EXHIBIT 19: US Elderly Population: Expected Growth Rates Over

the Years 2005-2025

EXHIBIT 20: North American Aging Population by Age Group: 1975-

2050

Select Product Categories in Rapid Microbiological Testing – An

Overview

Automated Susceptibility Testing Systems

STD Rapid Tests

Respiratory Rapid Tests

Streptococcus Infection Rapid Tests

Food Safety Microbiological Testing Market: Concerns over Food

Safety Drive Market Gains

EXHIBIT 21: Foodborne Illnesses, Hospitalizations and Deaths in

the US: Percentage Breakdown for Known Pathogens and

Unspecified Agents

EXHIBIT 22: Leading Pathogens Causing Foodborne Illnesses in

the US: Percentage Breakdown of Number of Illnesses by Known

Pathogens

EXHIBIT 23: Number of Food Recalls in the US: Breakdown by

Class I Recalls and Class II & III Recalls for 2014-2019

Market Analytics

Table 25: USA Current & Future Analysis for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical – Independent

Analysis of Annual Sales in US$ Thousand for the Years 2020

through 2027 and % CAGR

Table 26: USA Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

CANADA

Table 28: Canada Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

JAPAN

Market Overview

EXHIBIT 24: Breakdown of Population by Age Group in Japan:

2010, 2020, and 2025

COVID-19 Testing Market In Japan

Market Analytics

Table 31: Japan Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 33: Japan 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

CHINA

Market Overview

COVID-19 Testing Market

Market Analytics

Table 34: China Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 35: China Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 36: China 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

EUROPE

COVID-19 Pandemic Propels Demand for Rapid Microbiological Testing

Growth in Clinical Diagnostics Automation

Rise in Automated and Rapid Tests in Clinical Applications

Aging Demography: An Opportunity Indicator

Food Safety Testing Market in Europe: An Overview

Market Analytics

Table 37: Europe Current & Future Analysis for Automated and

Rapid Microbiological Tests by Geographic Region – France,

Germany, Italy, UK, Spain, Russia and Rest of Europe Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2020 through 2027 and % CAGR

Table 38: Europe Historic Review for Automated and Rapid

Microbiological Tests by Geographic Region – France, Germany,

Italy, UK, Spain, Russia and Rest of Europe Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 39: Europe 15-Year Perspective for Automated and Rapid

Microbiological Tests by Geographic Region – Percentage

Breakdown of Value Sales for France, Germany, Italy, UK, Spain,

Russia and Rest of Europe Markets for Years 2012, 2021 & 2027

Table 40: Europe Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 41: Europe Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 42: Europe 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

FRANCE

Table 43: France Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 44: France Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 45: France 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

GERMANY

Table 46: Germany Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 47: Germany Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 48: Germany 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

ITALY

Table 49: Italy Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 50: Italy Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 51: Italy 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

UNITED KINGDOM

Table 52: UK Current & Future Analysis for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical – Independent

Analysis of Annual Sales in US$ Thousand for the Years 2020

through 2027 and % CAGR

Table 53: UK Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 54: UK 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

SPAIN

Table 55: Spain Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 56: Spain Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 57: Spain 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

RUSSIA

Table 58: Russia Current & Future Analysis for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 59: Russia Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Independent Analysis of Annual Sales in US$ Thousand for Years

2012 through 2019 and % CAGR

Table 60: Russia 15-Year Perspective for Automated and Rapid

Microbiological Tests by Application – Percentage Breakdown of

Value Sales for GC/CRT (Clinical), AISS (Clinical), ABCS

(Clinical), SIRT (Clinical), ATS (Clinical), Other Applications

(Clinical) and Non-Clinical for the Years 2012, 2021 & 2027

REST OF EUROPE

Table 61: Rest of Europe Current & Future Analysis for

Automated and Rapid Microbiological Tests by Application –

GC/CRT (Clinical), AISS (Clinical), ABCS (Clinical), SIRT

(Clinical), ATS (Clinical), Other Applications (Clinical) and

Non-Clinical – Independent Analysis of Annual Sales in US$

Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Rest of Europe Historic Review for Automated and

Rapid Microbiological Tests by Application – GC/CRT (Clinical),

AISS (Clinical), ABCS (Clinical), SIRT (Clinical), ATS

(Clinical), Other Applications (Clinical) and Non-Clinical

Markets – Independent Analysis of Annual Sales in US$ Thousand

for Years 2012 through 2019 and % CAGR

Table 63: Rest of Europe 15-Year Perspective for Automated and

Rapid Microbiological Tests by Application – Percentage

Breakdown of Value Sales for GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical for the Years

2012, 2021 & 2027

ASIA-PACIFIC

Market Overview

Market Analytics

Table 64: Asia-Pacific Current & Future Analysis for Automated

and Rapid Microbiological Tests by Geographic Region –

Australia, India, South Korea and Rest of Asia-Pacific Markets –

Independent Analysis of Annual Sales in US$ Thousand for

Years 2020 through 2027 and % CAGR

Table 65: Asia-Pacific Historic Review for Automated and Rapid

Microbiological Tests by Geographic Region – Australia, India,

South Korea and Rest of Asia-Pacific Markets – Independent

Analysis of Annual Sales in US$ Thousand for Years 2012 through

2019 and % CAGR

Table 66: Asia-Pacific 15-Year Perspective for Automated and

Rapid Microbiological Tests by Geographic Region – Percentage

Breakdown of Value Sales for Australia, India, South Korea and

Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027

Table 67: Asia-Pacific Current & Future Analysis for Automated

and Rapid Microbiological Tests by Application – GC/CRT

(Clinical), AISS (Clinical), ABCS (Clinical), SIRT (Clinical),

ATS (Clinical), Other Applications (Clinical) and Non-Clinical –

Independent Analysis of Annual Sales in US$ Thousand for the

Years 2020 through 2027 and % CAGR

Table 68: Asia-Pacific Historic Review for Automated and Rapid

Microbiological Tests by Application – GC/CRT (Clinical), AISS

(Clinical), ABCS (Clinical), SIRT (Clinical), ATS (Clinical),

Other Applications (Clinical) and Non-Clinical Markets –

Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p04707098/?utm_source=GNW

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________


Roboticulized digests/handpicks the latest news about the artificial intelligence/machine learning industry and serves them to you daily. We provide you with the latest news and press releases straight from the AI/ML industry.
Hipther

FREE
VIEW